[1] 毛思颖,曹海明,陈前军,等.槐耳颗粒治疗乳腺癌的研究进展[J].中成药,2016,38(6):1363-1367. [2] Fairweather M , Jiang W , Keating NL , et al. Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Registry[J].Breast Cancer Res Treat, 2018,169 (2 ):287-293. [3] 牟鹏,厉红元.乳腺癌新辅助化疗的研究进展[J].中国普外基础与临床杂志,2011,18(9):1011-1016. [4] 荣庆林,王淑莲,唐玉,等.局部晚期乳腺癌新辅助化疗和改良根治术后放疗价值分析[J].中华放射肿瘤学杂志,2017,26(8):884-891. [5] 中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2007版)[J].中国癌症杂志,2007,17(5):410-428. [6] 孔凡立,赵洪远,冯国丽,等.T AC方案新辅助化疗对局部晚期乳腺癌患者的临床疗效及预后的影响[J].重庆医学,2016,45(10):1393-1395. [7] Khairallah AS , Genestie C , Auguste A , Leary A ,et al.Impact of neoadjuvant chemotherapy on the immune microenvironment in advanced epithelial ovarian cancer: Prognostic and therapeutic implications.International journal of cancer, 2018,143(1):8-15. [8] Huang O,Jiang M,Chen XS,et al. Prognostic factors of survival in pathologic incomplete response patients with locally advanced breast cancer after neoadjuvant chemotherapy[J].Cell Biochem Biophys,2015,71(2):1181-1190. [9] 徐兵河,罗扬,张频,等.新辅助化疗未达病理完全缓解的局部晚期乳腺癌患者的预后分析[J].中国肿瘤临床与复发,2014,20(4):455-459. [10] 郭金亮,陈红杰,董玮坡,等.保乳术、改良根治术及Halsted根治术治疗乳腺癌效果对比[J].青岛医药卫生,2011,43(3):186-188.
2018, Vol. 35 
